Oligonucleotide API Market Size

Oligonucleotide API Market size was over USD 2.4 billion in 2024 and is poised to exceed USD 8 billion by 2037, growing at over 9.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of oligonucleotide API is evaluated at USD 2.79 billion.

The growth of the market can be attributed to the rise in laboratory and research institute experiments worldwide. The Increasing use of oligonucleotides for various applications such as gene editing, diagnostics, therapeutics, and so on has driven the surge in interest in APIs across organizations. As per the data by the World Bank, as of 2018, there were 1597 researchers per 1,000,000 people involved in research and development activities across the globe, an increase from 1412 researchers per million in 2015. Further, the growing use of oligonucleotides in the effective treatment of several disorders is another major factor that is estimated to push the market growth further throughout the forecast period.

In addition to these, factors that are believed to fuel the market growth of oligonucleotide API include the worldwide rising proportion of oligonucleotide API in the drug pipeline which is estimated to accelerate the global oligonucleotide API market size in coming years. The oligonucleotide is a new type of therapeutic molecule ideal for treating a variety of diseases. Oligonucleotide base pairs with DNA or RNA to form a structure. In PCR (polymerase chain reaction), oligonucleotides are commonly used as primers. In addition, funding in life science activities, innovative product launches, and drug discovery, along with investments in high-profile big science projects are expected to drive demand for oligonucleotide API during the forecast period. For instance, according to estimates, governments around the world and international organizations are expected to invest a total of more than USD 170 billion on large-scale science projects between 2022 and 2025.